Melanoma - A multidisciplinary approach for the general surgeon

被引：11

作者：

Reeves, ME ^{[1
]}

Coit, DG ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA

来源：

SURGICAL CLINICS OF NORTH AMERICA | 2000年 / 80卷 / 02期

关键词：

D O I：

10.1016/S0039-6109(05)70202-4

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Surgery continues to be the primary treatment for malignant melanoma. Significant progress has been made in defining appropriate surgical therapy for various stages of the disease. Much of this progress has come from basic science research, which has helped develop active adjuvant therapies and molecular staging approaches. These advances have allowed the surgeon to undertake a multidisciplinary approach to the treatment of melanoma and to provide better outcomes for patients with this disease.

引用

页码：581 / +

页数：22

共 122 条

[41]

COIT D, 1998, P AN M AM SOC CLIN, V17, P514

[42] Quality-of-life - adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: An Eastern Cooperative Oncology Group Study [J].

Cole, BF ;

Gelber, RD ;

Kirkwood, JM ;

Goldhirsch, A ;

Barylak, E ;

Borden, E .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (10) :2666-2673

[43] RANDOMIZED, SURGICAL ADJUVANT CLINICAL-TRIAL OF RECOMBINANT INTERFERON ALFA-2A IN SELECTED PATIENTS WITH MALIGNANT-MELANOMA [J].

CREAGAN, ET ;

DALTON, RJ ;

AHMANN, DL ;

JUNG, SH ;

MORTON, RF ;

LANGDON, RM ;

KUGLER, J ;

RODRIGUE, LJ .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (11) :2776-2783

[44] LONG-TERM ADJUVANT IMMUNOTHERAPY IN STAGE-I HIGH-RISK MALIGNANT-MELANOMA, COMPARING 2 BCG PREPARATIONS VERSUS NON-TREATMENT IN A RANDOMIZED MULTICENTER STUDY (EORTC PROTOCOL 18781) [J].

CZARNETZKI, BM ;

MACHER, E ;

SUCIU, S ;

THOMAS, D ;

STEERENBERG, PA ;

RUMKE, P .

EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) :1237-1242

[45] RECENT CANCER TRENDS IN THE UNITED-STATES [J].

DEVESA, SS ;

BLOT, WJ ;

STONE, BJ ;

MILLER, BA ;

TARONE, RE ;

FRAUMENI, JF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (03) :175-182

[46]

EGGERMONT AM, 1998, EUR J CANC S3, V34, P22

[47]

FLEMING ID, 1997, AJCC CANC STAGING MA, V5, P163

[48] THE DETECTION OF MELANOMA-CELLS IN PERIPHERAL-BLOOD BY REVERSE TRANSCRIPTION-POLYMERASE CHAIN-REACTION [J].

FOSS, AJE ;

GUILLE, MJ ;

OCCLESTON, NL ;

HYKIN, PG ;

HUNGERFORD, JL ;

LIGHTMAN, S .

BRITISH JOURNAL OF CANCER, 1995, 72 (01) :155-159

[49] SPECIFIC DETECTION OF CARCINOEMBRYONIC ANTIGEN-EXPRESSING TUMOR-CELLS IN BONE-MARROW ASPIRATES BY POLYMERASE CHAIN-REACTION [J].

GERHARD, M ;

JUHL, H ;

KALTHOFF, H ;

SCHREIBER, HW ;

WAGENER, C ;

NEUMAIER, M .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :725-729

[50] Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma [J].

Gershenwald, JE ;

Colome, MI ;

Lee, JE ;

Mansfield, PF ;

Tseng, CH ;

Lee, JJ ;

Balch, CM ;

Ross, MI .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (06) :2253-2260

← 1 2 3 4 5 6 7 8 9 10 →